0001093557-15-000148.txt : 20150518 0001093557-15-000148.hdr.sgml : 20150518 20150518204252 ACCESSION NUMBER: 0001093557-15-000148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150514 FILED AS OF DATE: 20150518 DATE AS OF CHANGE: 20150518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREGG TERRANCE H CENTRAL INDEX KEY: 0001236388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 15874862 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-05-14 0 0001093557 DEXCOM INC DXCM 0001236388 GREGG TERRANCE H 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 1 1 0 0 Executive Chairman Common Stock 2015-05-14 4 M 0 25000.0 6.85 A 455626 D Common Stock 2015-05-14 4 S 0 25000.0 68.7094 D 430626 D Common Stock 2015-05-14 4 M 0 5000.0 3.19 A 435626 D Common Stock 2015-05-14 4 S 0 5000.0 68.2201 D 430626 D Common Stock 2015-05-18 4 M 0 37500.0 3.19 A 468126 D Common Stock 2015-05-18 4 S 0 37500.0 70.1527 D 430626 D Common Stock 2015-05-15 4 S 0 15000.0 68.1854 D 507139 I by Trust Common Stock 11461 I by IRA Non-Qualified Stock Option (right to buy) 3.19 2015-05-14 4 M 0 5000.0 68.2201 D 2009-12-11 2018-12-11 Common Stock 5000 75000 D Non-Qualified Stock Option (right to buy) 3.19 2015-05-18 4 M 0 37500.0 70.1527 D 2009-12-11 2018-12-11 Common Stock 37500 37500 D Non-Qualified Stock Option (right to buy) 6.85 2015-05-14 4 M 0 25000.0 68.7094 D 2008-06-19 2017-06-19 Common Stock 25000 300000 D This transaction was executed in multiple trades at prices ranging from $68.34 to $69.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 197,502 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 111,720 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 50,782 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016. This transaction was executed in multiple trades at prices ranging from $70.04 to $70.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $67.72 to $69.18. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. By: Jess Roper For: Terrance H. Gregg 2015-05-18